Quarterly report · Q2
8095.TEDINET S100RE4A
Period2022-12-01 → 2023-05-31
Filed2023-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.9bn | 2022-12-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥49.6bn | 2021-12-01 → 2022-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net sales |
| Operating income | ¥208m | 2022-12-01 → 2023-05-31 | Cons. | Operating income |
| Operating income | ¥720m | 2021-12-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥284m | 2022-12-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2021-12-01 → 2022-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥835m | 2021-12-01 → 2022-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥68m | 2022-12-01 → 2023-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2021-12-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥228m | 2022-12-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥933m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥236m | 2022-12-01 → 2023-05-31 | Cons. | Profit loss |
| Net income | ¥928m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥64.8bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥63.9bn | at 2022-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥38.2bn | at 2023-05-31 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2022-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥26.6bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥27.1bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥27.8bn | at 2022-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.4bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.9bn | at 2022-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.3bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2021-11-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥804m | 2022-12-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥742m | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.0bn | 2022-12-01 → 2023-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥639m | 2022-12-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2021-12-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.78 | 2022-12-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.55 | 2023-03-01 → 2023-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.56 | 2021-12-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.33 | 2021-12-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.08 | 2022-03-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 40.9% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.5% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 61
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-12-01 → 2023-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-12-01 → 2023-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥669,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-12-01 → 2023-05-31 | −¥49m |
| Reconciling Itemsreconciling | revenue | 2022-12-01 → 2023-05-31 | −¥841m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-12-01 → 2023-05-31 | −¥841m |
| Reconciling Itemsreconciling | segment profit | 2022-12-01 → 2023-05-31 | ¥18m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥7.8bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥7.3bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥559m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-05-31 | −¥84m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥8.9bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥8.8bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥56m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2022-12-01 → 2023-05-31 | ¥79m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥35m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-05-31 | −¥81m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2022-12-01 → 2023-05-31 | ¥6.6bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2022-12-01 → 2023-05-31 | ¥6.4bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥191m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2022-12-01 → 2023-05-31 | ¥326m |
| —segment total | revenue | 2022-12-01 → 2023-05-31 | ¥27.7bn |
| —segment total | revenue external | 2022-12-01 → 2023-05-31 | ¥26.9bn |
| —segment total | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥840m |
| —segment total | segment profit | 2022-12-01 → 2023-05-31 | ¥239m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-05-31 | ¥27.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-05-31 | ¥26.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-12-01 → 2023-05-31 | ¥841m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-05-31 | ¥190m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-05-31 | −¥19m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-05-31 | ¥17m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.5bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥348m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥474m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.3bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.2bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥105m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥66m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥4.3bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥52m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥38m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥6.1bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥235m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥353m |
| —segment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| —segment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| —segment total | segment profit | 2021-12-01 → 2022-05-31 | ¥722m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-05-31 | ¥704m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 636
| Item | Context | Value | Unit |
|---|---|---|---|
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | 279684000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -52026000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 781158000 | JPY |
| Increase decrease in accrued expenses ope cf | Prior1YTDDuration | -594396000 | JPY |
| Increase decrease in accrued expenses ope cf | CurrentYTDDuration | 200737000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | -51373000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -17858000 | JPY |
| Decrease increase in advance payments ope cf | Prior1YTDDuration | 30660000 | JPY |
| Decrease increase in advance payments ope cf | CurrentYTDDuration | -100149000 | JPY |
| Increase decrease in refund liabilities ope cf | Prior1YTDDuration | 63580000 | JPY |
| Increase decrease in refund liabilities ope cf | CurrentYTDDuration | -73627000 | JPY |
| Decrease increase in claims provable in bankruptcy claims provable in rehabilitation ope cf | Prior1YTDDuration | -500000 | JPY |
| Decrease increase in claims provable in bankruptcy claims provable in rehabilitation ope cf | CurrentYTDDuration | － | JPY |
| Decrease increase in other current assets ope cf | Prior1YTDDuration | 23377000 | JPY |
| Decrease increase in other current assets ope cf | CurrentYTDDuration | -28186000 | JPY |
| Increase decrease in other current liabilities ope cf | Prior1YTDDuration | 219509000 | JPY |
| Increase decrease in other current liabilities ope cf | CurrentYTDDuration | 126429000 | JPY |
| Other net ope cf | Prior1YTDDuration | 170961000 | JPY |
| Other net ope cf | CurrentYTDDuration | 71548000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 2060107000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 1584903000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 28667000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 30198000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -27318000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -28298000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -872143000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -871422000 | JPY |
| Income taxes refund ope cf | Prior1YTDDuration | 139515000 | JPY |
| Income taxes refund ope cf | CurrentYTDDuration | 88843000 | JPY |
| Payments for directors retirement benefits ope cf | Prior1YTDDuration | － | JPY |
| Payments for directors retirement benefits ope cf | CurrentYTDDuration | -690000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 1328828000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 803534000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -689850000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -2795376000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 1388441000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 81980000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -142398000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -88511000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -148130000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -73257000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | -76937000 | JPY |
| Payments for transfer of business2 inv cf | Prior1YTDDuration | -627015000 | JPY |
| Payments for transfer of business2 inv cf | CurrentYTDDuration | － | JPY |
| Subsidies received inv cf | Prior1YTDDuration | 8300000 | JPY |
| Subsidies received inv cf | CurrentYTDDuration | 30066000 | JPY |
| Other net inv cf | Prior1YTDDuration | 187766000 | JPY |
| Other net inv cf | CurrentYTDDuration | -28280000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -22888000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |